<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type='text/xsl' href='http://www.sanofipasteur.com.au/sanofi-pasteur2/rss/san-rssFeed.xsl' media='screen'?>
<rss version="2.0" xml:lang="EN">
  <channel>
    <title />
    <description>AUSTRALIA Latest press releases</description>
    <link>http://www.sanofipasteur.com.au/sanofi-pasteur2/front/index.jsp?siteCode=AVPI_AU&amp;codeRubrique=34&amp;lang=EN</link>
    <language>EN</language>
    <pubDate>05/09/2010</pubDate>
    <item>
      <pubDate>March 26, 2009</pubDate>
      <link>http://www.sanofipasteur.com.au/sanofi-pasteur2/ImageServlet?imageCode=26126&amp;siteCode=AVPI_AU</link>
      <title>EMERFLU®, pandemic influenza vaccine for humans, approved in Australia</title>
    </item>
    <item>
      <pubDate>February 18, 2009</pubDate>
      <link>http://www.sanofipasteur.com.au/sanofi-pasteur2/ImageServlet?imageCode=25557&amp;siteCode=AVPI_AU</link>
      <title>Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study</title>
    </item>
    <item>
      <pubDate>February 17, 2009</pubDate>
      <link>http://www.sanofipasteur.com.au/sanofi-pasteur2/ImageServlet?imageCode=25556&amp;siteCode=AVPI_AU</link>
      <title>Sanofi Pasteur starts a phase II study of a vaccine against Clostridium difficile</title>
    </item>
    <copyright />
  </channel>
</rss>

